Takizawa J, Teshima T, Ennishi D, Ichikawa S, et al. Safety and efficacy of acalabrutinib and obinutuzumab in treatment-naive chronic lymphocytic leukemia: a Japanese phase 1 study. Leuk Lymphoma 2024 Jul 1:1-9. doi: 10.1080/10428194.2024.2370436.
PMID: 38952054